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ABSTRACT
Objective: The aim of the present study is to enhance the dissolution rate of candesartan cilexetil (CC) using microsponges. Candesartan is 
therapeutically a potent antihypertensive agent, but it suffers a major drawback of poor oral bioavailability, which is estimated to be 15% due to its 
low solubility in the gastrointestinal fluids and hepatic first-pass metabolism.
Methods: Eudragit-based microsponges were prepared by quasi-emulsion solvent diffusion method using different drug–polymer ratios (1:1 to 1:6), 
stirring speeds (250–750 rpm), and emulsifier concentrations (polyvinyl alcohol) (0.05%–0.083% w/v). Differential scanning calorimetry (DSC) and 
Fourier transform infrared spectroscopy (FTIR) study for CC, physical mixtures of drug–polymer, and selected formula were investigated to estimate 
compatibility of CC with other used ingredients. All formulations were evaluated for particle size, production yield, and loading efficiency. The in vitro 
drug release study of optimized formulation was performed in phosphate buffer pH 6.8.
Results: The obtained results indicated that formula F3 which contains eudragit RS100 at drug:polymer ratio (6:1) was showed the smallest particle 
size with higher production yield and loading efficiency. DSC and FTIR study of the physical mixtures of drug and polymer revealed no drug–polymer 
interaction. The results clearly confirm that the percentage of CC released at 30 min from F3, CC powder, and self-made tablet was 54%, 20.325, and 
38.9%, respectively.
Conclusion: Microsponges technique was considered as a promising system to enhance the solubility and dissolution rate of poor-water soluble CC.
Keywords: Candesartan cilexetil, Eudragit, Microsponges, Polyvinyl alcohol, Quasi-emulsion solvent diffusion method.
INTRODUCTION
In the recent years, there has been a considerable importance given to 
the development of novel microsponge-based drug delivery systems, 
in order to modify and control the release behavior of the drugs [1]. 
Microsponges are polymeric delivery systems composed of porous 
microspheres. They are tiny sponge-like spherical particles with a 
large porous surface. Moreover, they may enhance stability, reduce side 
effects, and modify drug release favorably.
Microsponge technology has many favorable characteristics, which make 
it a versatile drug delivery vehicle. Microsponge systems are based on 
microscopic, polymer-based microspheres that can suspend or entrap a 
wide variety of substances and can then be incorporated into a formulated 
product such as a gel, cream, liquid, or powder [2]. These particles are 
capable of carrying both lipophilic and hydrophilic substances and of 
improving the solubility of poor water-soluble molecules [3].
Candesartan cilexetil (CC) is widely used for the treatment of 
hypertension and heart failure in clinical application. It is a selective 
AT1 subtype angiotensin II receptor antagonist. After the oral 
administration, it undergoes rapid ester hydrolysis to convert to 
the active Candesartan during absorption in the gastrointestinal 
tract [4].
CC shows a very poor solubility within the physiological pH range, 
which could result in incomplete intestinal absorption and a very low 
systemic exposure.Due to its low solubility and a slow dissolution 
rate therefore the oral administration of CC has an oral bioavailability 
of about 15% which needs to be enhanced. CC is a highly lipophilic 
compound. Therefore, it is necessary to find a new approach to enhance 
the oral bioavailability of the drug [5].
In this work, we designed and developed CC microsponges to improve 
the dissolution rate and enhance the bioavailability. CC microsponges 
were prepared by quasi-emulsion solvent diffusion method.
MATERIALS AND METHODS
Materials
CC was purchased from Shenzhen Nexconn Pharma Techs Ltd, China. 
Eudragit RS 100, Eudragit RL100, and Eudragit S100 was purchased 
from Rohm Pharma, Germany. Dichloromethane was obtained 
from GCC Analytical Reagent, UK. Ethanol was purchased from 
Sigma-Aldrich, Germany. Methanol was obtained from Thomas Baker 
chemical, Mumbai, India. Glycerol was obtained from BDH, England. 
Polyvinyl alcohol (PVA), disodium hydrogen phosphate, and potassium 
dihydrogen phosphate were obtained from SD Fine Chem limited, 
Mumbai, India. All other chemicals used were of analytical grades.
Methods
Preparation of CC microsponges
The microsponges enclosing CC were fabricated by quasi-emulsion 
solvent diffusion method. In the present study, ethanol, which is capable 
of dissolving both the drug and the polymer, was selected as the internal 
solvent. The inner phase comprises eudragit (as mentioned in Table 1) 
dissolved in 5 ml of ethanol. Once a clear solution was obtained, then 
the CC was added and dissolved through ultrasonication at 35°C for 
15 min to obtain a homogenous clear solution then 0.5 ml glycerol was 
added to the mixture.
Followed by drop-wise addition of this mixture into an aqueous solution 
of PVA (outer phase) with different stirring rates 250, 500, and 750 rpm 
for 60 min. Subsequently, microsponges were formed due to the ethanol 
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removal from the system by evaporation. The prepared microsponges 
were then filtered, washed with distilled water, and subjected to drying 
at 40°C for 24 h in hot air oven. Finally, microsponges obtained were 
weighed to determine the production yield [6]. Various formulation 
batches were prepared as per Table 1.
Determination of the production yield
The percentage of the production yield was calculated from the weight 
of the dried microsponges (W1) and the sum of the initial dry weight of 
starting materials (W2) as the following equation:
% Production Yield = W1/W2 × 100.
The determinations were done in triplicate [7].
Determination of loading efficiency
10 mg of microsponges were accurately weighed. They were powdered 
and extracted with 100 ml of ethanol. The resulting solution was 
analyzed for CC content by measuring absorbance in an ultraviolet-
spectrophotometer at 254 nm. The studies were carried out in triplicate. 
Loading efficiency (%) was calculated using the following equation [8].






Determination of the average particle size of CC-loaded microsponges 
was determined with an optical microscope using a calibrated ocular 
and stage micrometer under a regular polarized light. A minute quantity 
of microsponges was spread on a clean glass slide and the average 
particle size was calculated by measuring 100 particles of each batch [9].
dav= ∑ nd ∕ ∑n
Where dav is the average diameter of particles (μm), n is number of 
particles per group, and d is the middle value (μm).
Differential scanning calorimetry (DSC)
Thermal analysis using DSC was carried out on drug, physical mixture 
of the drug and eudragit RS100, and the selected formula to determine 
the compatibility between the drug and excipients. Accurately weighed 
sample was loaded into an aluminum pan and sealed. Samples were run 
at a heating rate of 10°C/min over a temperature range 0–300°C in an 
atmosphere of nitrogen [10].
Fourier transform infrared spectroscopy (FTIR)
CC and the optimized formula (F3) were subjected to IR analysis; the 
samples were scanned in the range from 400 cm−1 to 4000 cm−1 and 
recorded on an FTIR, using the KBr disk technique [11].
Scanning electron microscope (SEM)
The microsponge formulations were visualized by SEM to assess the 
morphology of the microsponges and surface. Samples were coated with 
gold–palladium under an argon atmosphere at room temperature, and 
the morphology of the microsponges was studied with SEM at 5kV [12].
In vitro dissolution study
The dissolution rates for the prepared microsponges formulae were 
carried out using USP paddle method at 50 rpm in 900 ml of phosphate 
buffer H 6.8 containing 0.35% w/v Tween 20 as a dissolution media, 
maintained at 37±0.5°C. The samples were collected at specified time 
intervals (5, 10, 15, 20, 25, and 30 min), filtered through Whatmann 
filter paper and assayed spectrophotometrically at 254 nm. An equal 
volume of fresh medium, which was pre-warmed at 37°C, was replaced 
into the dissolution media after each sampling to maintain a constant 
volume throughout the test [13,14].
Statistical analysis
The data obtained from each experiment were subjected to 
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office Excel 2010. p<0.05 was considered to be indicative of 
significance [15].
RESULTS AND DISCUSSION
Formulation of CC microsponges
CC-loaded microsponges were prepared by quasi-emulsion solvent 
diffusion method which is appeared to be promising for the preparation 
of CC microsponges as it is easy, reproducible, rapid, and has the 
advantage of avoiding solvent toxicity [16].
CC-loaded microsponges were prepared from different types of 
polymer (Eudragit RS100, RL100, and S100) which are biologically 
inert, non-irritating, non-mutagenic, non-allergenic, non-toxic, and 
non-biodegradable polymers. As a result, the human body cannot 
convert them into other substances or break them down, so when these 
polymers administered orally, they are excreted unchanged with the 
remaining food [16].
Because of its simplicity and reproducibility, quasi-emulsion solvent 
diffusion method was used for the preparation of microsponges. 
Moreover, it has the advantage of avoiding solvent toxicity [10]. 
The production yield of all formulas lies between 60 and 85.51%, 
all formulas have an acceptable loading efficiency ranged from 66 
to 93%, there is a significant difference (p<0.05) between the three 
polymer types in case of production yield and loading efficiency. 
Regarding the particle size of the prepared microsponges, the mean 
lies between (79 µm and 128 µm), finally the results are depicted in 
Table 2.
Effect of formulation variables on loading efficiency, production 
yield, and particle size
Effect of drug:polymer ratios
First, nine formulas were prepared to study the CC microsponges using 
different type of polymers (eudragit RS100, RL100, and S100), also 
different drug:polymer ratio (1:1, 3:1, and 6:1).
The loading efficiencies calculated for all microsponges ranged from 
66% to 89.48%. The highest loading efficiency was found for the F3 
formulation which composed of RS100 and higher drug:polymer ratio 
(6:1), where a greater amount of drug was encapsulated. The highest 
the loading efficiency, greater the amount of drug was encapsulated. 
The reason for the increase in EE with high polymer ratios is reduced 
diffusion rate of drug solution from concentrated polymeric solutions 
into external phase. As a result, the amount of the drug diffused and 
flux of the formulations was decreased at a higher drug:polymer 
ratio. This provides more time for the droplet formation and it may 
improve microsponges yield and entrapment efficiency [17].
It has been observed that an increase in the drug:polymer ratio resulted 
in an increase in the production yield as in Table 2. This is because 
as the drug:polymer ratio went on increasing, the polymer amount 
available for each microsponge to encapsulate the drug was more, thus 
rising polymer matrix wall thickness which led to extended diffusion 
path and ultimately to lesser drug release. As a result, the amount of 
drug diffused and flux of the formulations was decreased at a higher 
drug:polymer ratio [18].
The mean particle size of the formulations was between 81.47 and 
115.7 µm. There was a significant difference between formulations 
(p<0.05) in the mean particle size. The results show that changing 
drug:polymer ratio has a considerable effect on the size of the prepared 
CC microsponges. Increasing the polymer fraction significantly increased 
the particle size (p<0.05). This could probably be due to increasing the 
amount of polymer available per microsponge, hence larger particle size 
was obtained. Previously published data have shown similar findings. 
Another explanation of this enlargement arouse from the more viscous 
polymer solution resulting from increasing the polymer fraction. This 
increase in viscosity hindered the breaking of emulsion into smaller 
droplets resulting in microsponges with larger particle size [19].
From all the above, microsponges formulae (F3) prepared from RS 100 
at the ratio of (6:1) shows higher loading efficiency and production yield 
89.48±1 and 75.51±1.5, respectively. Furthermore, formula F3 showed 
the smallest particle size (81.47±2.1 µm) therefore will be chosen for 
studying the effect of other factor on the prepared CC microsponges.
Effect of volume and type of internal phase on microsponges
Regarding the solvent type, ethanol significantly increases the loading 
efficiency when compared to methylene chloride and methanol. This 
may be due to the higher boiling point of ethanol (78.4°C) compared 
to methylene chloride (40°C) and methanol (64.7°C), so ethanol would 
evaporate more slowly than methylene chloride. The lower organic 
solvent evaporation rate led to a lower solvent front kinetic energy, 
which accordingly decreased the rate of diffusion of the solvent from 
the inner to the outer phase so increasing the chance for entrapping the 
drug inside the polymer [20].
However, the particle size was slightly increased (non-significant 
p>0.05) when ethanol is used since a critical parameter determining 
the particle size seems to be the rate of diffusion of the organic solvent 
through the interface. At higher diffusion rates, smaller particles are 
obtained. Increased solvent front kinetic energy causes a higher degree 
of the droplet dispersion in the aqueous phase [21].
Table 2: Properties of the prepared CC microsponges for the prepared formulas
Formula Production yield* %±SD Loading efficiency* %±SD Mean particle size* (µm)±SD
F1 67.12±2.1 72.22±1.2 101.17±2.51
F2 76.35±1.2 70.2±1.1 95.89±1.7
F3 85.51±1.5 89.48±1 81.47±2.1
F4 61.52±1.41 74.87±1.4 115.7±2.9
F5 65.74±1.51 78.8±2.1 100.57±1.8
F6 72.47±1.3 86.23±1.8 89.4±1.91
F7 60±2.7 66±1.1 106±1.8
F8 64±2.4 69±1.5 95±2.02
F9 70±1.7 77±2.1 87±2.07
F10 76±1.2 93±1.5 79±1.7
F11 - - -
F12 83±1.8 79±2.1 83±2.1
F13 78±1.6 74±1.4 84±1.8
F14 75.1±2.1 77±1.5 110±2.1
F15 69±2.4 69±2.2 121±3.2
F16 74±1.8 76±1.7 74±1.5
F17 83±1.8 84±1.8 128±1.2
*All values are expressed as mean±SD, n=3. SD: Standard deviation, CC: Candesartan cilexetil
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Regarding the volume of ethanol used. It was observed that on 
increasing the internal phase volume from 7.5 to 10 ml microsponges 
were not formed. This may be due to the decrease in the viscosity of 
the internal phase. In this study, it was observed that the particle size, 
the production yield, and the drug content decreased on increasing 
the internal phase. These results suggest that the amount of ethanol 
need to be controlled within an appropriate range to affect not only the 
formation of quasi-emulsion but also the solidification of the drug and 
polymer in the droplets [22]. The best microsponges were produced as 
better when 5 ml of ethanol was used as shown in Table 2.
Effect of external phase
The results indicate that changing the external phase concentration 
(F3, F14, and F15) caused a significant effect (p<0.05) reduction in the 
EE% and production yield of the prepared CC microsponges as shown 
in Table 2. This may be because the emulsifier employed (PVA) was non-
ionic and molecules can associate away from the oil–water interface 
at higher concentrations. Such alternative hydrophobic region can 
dissolve some portions of the drug resulting in a reduction in the loading 
efficiency and the production yield within the microsponge formulations. 
The results showed that bigger microsponges were obtained when the 
concentration of PVA was higher. An increase in mean particle size of 
microsponges with an increase in the emulsifier concentration can be 
attributed to an increase in the apparent viscosity at increased emulsifier 
concentrations. Such increased viscosity would result in larger emulsion 
droplets and finally in greater microsponge size [23,24].
Effect of stirring rate
It was observed that increasing stirring speed decreases the % loading 
efficiency and decrease of the mean particle size. It was found that 
the stirring rate of the emulsion influences the particle size and its 
distribution greatly due to the turbulence created within the external 
phase. It was found that lowering the stirring speed leads to an 
increase in mean particle due to the increased tendency of globules 
to aggregation and coalescence, while at higher stirring rates, forceful, 
even, improved mechanical shear might force and resulted in a rapid 
dispersion of droplets having less chance of coalescing into bigger 
droplets [25].
In vitro drug dissolution study
The dissolution study was performed for the formula that has a better 
production yield, loading efficiency, and the smaller particle size and 
also for pure CC powder. The drug release profile of the microsponge 
formulation showed that cumulative percent drug release was high in 
the first ½ h (Fig. 1).
Tween 20 was selected as a solubilizer due to its ability to increase 
CC aqueous solubility so that a good sink condition (below 20% of 
saturated solubility of drug) could be maintained [14]. The extent of 
drug release from oral formulations is determined by the dissolution 
rates of drug, which is a function of aqueous solubility and particle size 
and it is usually a diffusion-controlled process.
On the other hand, the in vitro drug release reveals that F3 was found 
to be better than the self-made tablet and CC powder due to the high 
thermodynamic activity of drug. The results clearly confirm that the 
percentage released of CC from F3 reached (54%) within 30 min, while 
the CC powder had about (20.325%) content dissolved after 30 min and 
self-made tablet (8 mg) had (38.9%) content dissolved after 30 min as 
shown by Fig. 1. The porous surface of the carrier particle enables easy 
penetration of the release media and its accessibility to the entrapped 
drug molecule.
Burst release was observed, which could be due to the surface 
adsorbed drug and the well-known porous nature of microsponges, 
the pores providing channels for drug release. Majority of 
the drug molecules may reside on the particulate surface as 
adsorbed molecules that have the probability of undergoing quick 
solubilization and hence quick drug release. But after achieving 
equilibrium, the rate of drug release decreased. These results 
rationalize the importance of the microsponge formulation due 
to increase of the surface area of the drug which will increase of 
dissolution rate [16].
SEM study
SEM of the prepared microsponges revealed a porous nature of the CC 
microsponges (Fig. 2).
Fig. 1: Cumulative drug release profile of selected formula (F3) 
Candesartan cilexetil (CC) microsponges; CC powder; self-made 
tablet using phosphate buffer pH 6.8 with 0.35% w/v Tween 20 as 
a dissolution medium, maintained at 37±0.5°C
Fig. 2: (a-d) Scanning electron microscope of Candesartan cilexetil 
microsponges
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crystalline state [26]. The thermogram of prepared CC microsponges 
1:6 (Fig. 4) displayed the microsponges structure is amorphous as 
no sharp melting peak is shown; this was an expected result because 
microsponges, as all cross-linked polymers, do not exhibit any melting 
point [27].
FTIR study
All the characteristic peaks of CC were present in the spectrum of drug 
and prepared CC microsponges, indicating compatibility between 
drug and polymer. The spectrum confirmed that there is no significant 
change in the chemical integrity of the drug. There is no change in 
functional group peaks (-C-H, C-N, N-H, C-O-C, C=O) of CC in all the IR-
spectra and is shown in Fig. 5.
CONCLUSION
On the basis of obtained results, one can conclude that RS100 was 
the best polymer for the formulation of CC microsponges. The overall 
results suggest that drug: polymer ratio of (6:1) is suitable for the 
preparation of CC microsponges which shows the higher production 
yield and loading efficiency and smallest particle size.
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Fig. 4: Differential scanning calorimetry thermogram of 
candesartan cilexetil microsponges
Fig. 5: Fourier transform infrared spectroscopy of (a) pure candesartan cilexetil (CC) (b) CC microsponges
Compatibility studies
DSC study
The DSC studies are used routinely to evaluate the crystalline state 
of the drug to demonstrate a possible interaction between the drug 
and other excipients and to provide information about the physical 
properties of the drug.
The DSC thermograms of pure CC (Fig. 3) showed a sharp endothermic 
peak at 175°C, which is its melting point as it melts with decomposition. 
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